Mother-to-child transmission of HIV in Kenya: A cross-sectional analysis of the national database over nine years

PLoS One. 2017 Aug 29;12(8):e0183860. doi: 10.1371/journal.pone.0183860. eCollection 2017.

Abstract

Objective: To describe factors associated with mother-to-child HIV transmission (MTCT) in Kenya and identify opportunities to increase testing/care coverage.

Design: Cross-sectional analysis of national early infant diagnosis (EID) database.

Methods: 365,841 Kenyan infants were tested for HIV from January 2007-July 2015 and results, demographics, and treatment information were entered into a national database. HIV risk factors were assessed using multivariable logistic regression.

Results: 11.1% of infants tested HIV positive in 2007-2010 and 6.9% in 2014-2015. Greater odds of infection were observed in females (OR: 1.08; 95% CI:1.05-1.11), older children (18-24 months vs. 6 weeks-2 months: 4.26; 95% CI:3.87-4.69), infants whose mothers received no PMTCT intervention (vs. HAART OR: 1.92; 95% CI:1.79-2.06), infants receiving no prophylaxis (vs. nevirapine for 6 weeks OR: 2.76; 95% CI:2.51-3.05), and infants mixed breastfed (vs. exclusive breastfeeding OR: 1.39; 95% CI:1.30-1.49). In 2014-2015, 9.1% of infants had mothers who were not on treatment during pregnancy, 9.8% were not on prophylaxis, and 7.0% were mixed breastfed. Infants exposed to all three risky practices had a seven-fold higher odds of HIV infection compared to those exposed to recommended practices. The highest yield of HIV-positive infants were found through targeted testing of symptomatic infants in pediatric/outpatient departments (>15%); still, most infected infants were identified through PMTCT programs.

Conclusion: Despite impressive gains in Kenya's PMTCT program, some HIV-infected infants present late and are not benefitting from PMTCT best practices. Efforts to identify these early and enforce evidence-based practice for PMTCT should be scaled up. Infant testing should be expanded in pediatric/outpatient departments, given high yields in these portals.

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active*
  • Cross-Sectional Studies
  • Databases, Factual
  • Female
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy*
  • Humans
  • Infant
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Kenya
  • Mothers
  • Nevirapine / therapeutic use*
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*
  • Retrospective Studies

Substances

  • Anti-HIV Agents
  • Nevirapine

Grants and funding

The authors wish to thank the Centers for Disease Control and Prevention (CDC), USAID/PEPFAR, and UNITAID for funding HIV diagnostics in Kenya. The IT infrastructure was funded by Hewlett-Packard. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.